ALB and Hypoalbuminemia: “SAFE Study Investigator reported that approximately 40% of critically ill patients presented with hypoalbuminemia, because cefoperazone, meropenem, and imipenem are highly bound to albumin, which could increase the unbound fraction significantly. Therefore, various pathological characteristics in critically ill patients may induce a wide discrepancy in the unbound fraction concentrations.” [34]